Polyphenols for the prevention and treatment of dementia diseases

Neural Regeneration Research

Volumn 10, Issue 11, 2015, Pages 1756-1758

  Hügel, Helmut M ^a   Jackson, Neale ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; CURCUMIN; EPICATECHIN; EPIGALLOCATECHIN; POLYPHENOL;

ALZHEIMER DISEASE; CACAO; DEMENTIA; DIET; DNA DAMAGE; GENE EXPRESSION; NOTE; PROTEIN INTERACTION; PROTEIN PROCESSING; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 84949456888     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.169609     Document Type: Note

References (13)

1. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367: 795-804.
2. Cox CJ, Choudhry F, Peacey E, Perkinton MS, Richardson JC, Howlett DR, Lichtenthalter SF, Francis PT, Williams RJ (2015) Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing. Neurobiol Aging 36: 178-187.
3. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15: 558-566.
4. Hugel HM (2015) Brain food for AD-free ageing: focus on herbal medicines. Natural compounds as therapeutic agents for amyloidogenic disease. Adv Exp Med Biol 863: 95-116.
5. Hugel HM, Jackson N (2014) Danshen diversity defeating dementia. Bioorg Med Chem Lett 24: 708-716.
6. Hugel HM, Jackson N (2014) Herbs and Dementia: a focus on dietary herbs and antioxidants. Diet and Nutrition in Dementia and Cognitive Decline, Academic Press.
7. Liu J, Liu S, Matsumoto Y, Murakami S, Sugakawa Y, Kami A, Tanabe C, Maeda T, Michikawa M, Komano H, Zou K (2015) Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology. Sci Rep 5: 12059.
8. Narayan P, Holmstrom KM, Kim DH, Whitcomb DJ, Wilson MR, St. Georg-Hyslop P, Wood NW, Dobson CM, Cho K, Abramov AY, Klenerman D (2014) Rare individual amyloid-β oligomers act on astrocytes to initiate neuronal damage. Biochem 53: 2442-2453.
9. Ulijaszek SJ, Mann N, Elton S (2012) Evolving human nutrition: implications for public health. Cambridge University Press.
10. Wong ND (2014) Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 11: 276-289.
11. Yau WY, Tudorascu DL, McDade EM, Ikonomovic S, James JA, Minhas D, Mowrey W, Sheu LK, Snitz BE, Weissfeld L, Gianaros PJ, Aizenstein HJ, Price JC, Mathis CA, Lopez OL, Klunk WE (2015) Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study. Lancet Neurol 14: 804-813.
12. Zhong W, Huan XD, Cao Q, Yang J (2015) Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats. Exp Ther Med 9: 405-410. 2015.
13. Alzheimer's disease facts and figures (2015) Alzheimers Dement 11: 332-384.